LUZP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.609600E-01
Normal-vs-Stage2
3.941200E-01
Normal-vs-Stage3
1.934380E-01
Normal-vs-Stage4
9.255000E-01
Stage1-vs-Stage2
4.676600E-01
Stage1-vs-Stage3
3.971200E-01
Stage1-vs-Stage4
3.750400E-01
Stage2-vs-Stage3
1.598420E-01
Stage2-vs-Stage4
4.547600E-01
Stage3-vs-Stage4
2.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.184400E-01
Normal-vs-AfricanAmerican
9.040000E-01
Normal-vs-Asian
2.016200E-01
Caucasian-vs-AfricanAmerican
2.682200E-01
Caucasian-vs-Asian
2.364000E-01
AfricanAmerican-vs-Asian
1.623370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.738200E-01
Normal-vs-Female
3.431000E-01
Male-vs-Female
9.954000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.893000E-01
Normal-vs-Age(41-60Yrs)
7.453200E-01
Normal-vs-Age(61-80Yrs)
2.346800E-01
Normal-vs-Age(81-100Yrs)
3.029000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.044370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.861000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.795400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.724860E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.334570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.199200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.839440E-01
Normal-vs-Daily Drinker
2.190800E-01
Normal-vs-Weekly Drinker
3.329400E-01
Normal-vs-Occasional Drinker
5.992800E-01
Normal-vs-Social Drinker
6.517800E-01
Non Drinker-vs-Daily Drinker
8.384800E-01
Non Drinker-vs-Weekly Drinker
6.031800E-01
Non Drinker-vs-Occasional Drinker
1.310560E-01
Non Drinker-vs-Social Drinker
1.747980E-01
Daily Drinker-vs-Weekly Drinker
7.387800E-01
Daily Drinker-vs-Occasional Drinker
2.061800E-01
Daily Drinker-vs-Social Drinker
2.580800E-01
Weekly Drinker-vs-Occasional Drinker
4.203200E-01
Weekly Drinker-vs-Social Drinker
4.731600E-01
Occasional Drinker-vs-Social Drinker
9.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.212800E-01
Normal-vs-Grade 2
5.889200E-01
Normal-vs-Grade 3
1.352970E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.268500E-02
Grade 1-vs-Grade 3
7.597800E-02
Grade 1-vs-Grade 4
4.212800E-01
Grade 2-vs-Grade 3
9.096800E-01
Grade 2-vs-Grade 4
5.889200E-01
Grade 3-vs-Grade 4
1.352970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.726000E-01
Normal-vs-NonDiabetic
2.530600E-01
Diabetic-vs-NonDiabetic
8.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.947400E-01
Normal-vs-NoPancreatitis
3.233200E-01
Pancreatitis-vs-NoPancreatitis
6.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.142800E-01
Normal-vs-N1
4.015200E-01
N0-vs-N1
4.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.287200E-01
Normal-vs-TP53-NonMutant
2.870400E-01
TP53-Mutant-vs-TP53-NonMutant
5.167600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
